Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1D | P28221 | 10/20 | 0.63 |
| ▸ | HTR1A | P08908 | 8/20 | 0.63 |
| ▸ | HTR2C | P28335 | 8/20 | 0.63 |
| ▸ | HTR1B | P28222 | 8/20 | 0.63 |
| ▸ | HTR2A | P28223 | 7/20 | 0.63 |
| ▸ | HTR2B | P41595 | 6/20 | 0.63 |
| ▸ | HTR6 | P50406 | 6/20 | 0.63 |
| ▸ | HTR3E | A5X5Y0 | 4/20 | 0.63 |
| ▸ | HTR3B | O95264 | 4/20 | 0.63 |
| ▸ | HTR1E | P28566 | 4/20 | 0.63 |
| ▸ | HTR1F | P30939 | 4/20 | 0.63 |
| ▸ | HTR7 | P34969 | 4/20 | 0.63 |
| ▸ | HTR3A | P46098 | 4/20 | 0.63 |
| ▸ | HTR5A | P47898 | 4/20 | 0.63 |
| ▸ | HTR4 | Q13639 | 4/20 | 0.63 |
| ▸ | HTR3D | Q70Z44 | 4/20 | 0.63 |
| ▸ | HTR3C | Q8WXA8 | 4/20 | 0.63 |
| ▸ | MPO | P05164 | 1/20 | 0.60 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15701917 | 0.87 | HTR1D (0.57) | HTR1DHTR1AHTR2CHTR1BHTR2A | |
| SCHEMBL15701953 | 0.86 | HTR1D (0.56) | HTR1DHTR1AHTR2CHTR1BHTR2A | |
| SCHEMBL25747400 | 0.85 | HTR1A (0.73) | HTR1DHTR1AHTR2CHTR1BHTR2A | |
| SCHEMBL30483760 | 0.85 | HTR1A (0.73) | HTR1DHTR1AHTR2CHTR1BHTR2A | |
| SCHEMBL517481 | 0.81 | HTR1D (0.61) | HTR1DHTR1AHTR2CHTR1BHTR2A | |
| SCHEMBL30483734 | 0.81 | HTR1A (0.74) | HTR1DHTR1AHTR2CHTR1BHTR2A | |
| SCHEMBL25747532 | 0.81 | HTR1A (0.74) | HTR1DHTR1AHTR2CHTR1BHTR2A | |
| SCHEMBL26203596 | 0.80 | HTR1A (0.51) | HTR1DHTR1AHTR2CHTR1BHTR2A | |
| SCHEMBL15701982 | 0.80 | HTR2A (0.70) | HTR1DHTR1AHTR2CHTR1BHTR2A | |
| SCHEMBL29633081 | 0.80 | HTR1A (0.70) | HTR1DHTR1AHTR2CHTR1BHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9278959-B2 | Processes and reagents for making diaryliodonium salts | NUTECH VENTURES (US) | 2016-03-08 | — | — | US | disclosed |
| US-20140121371-A1 | PROCESSES AND REAGENTS FOR MAKING DIARYLIODONIUM SALTS | Ground Fluor Pharmaceuticals, Inc. (US) | 2014-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140121371-A1 | PROCESSES AND REAGENTS FOR MAKING DIARYLIODONIUM SALTS | ABL1, ARSA, AADAC | HTR1D 3291/4885HTR1A 3821/4885HTR2C 2929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.